Stock Evaluator: Endovia Health Sciences, Inc. (EDVA)
Endovia Health Sciences, Inc. EDVA
$0.26
0.00
-1.68%
September 4, 2026 4:00:00 PM
EST
Volume: 70,159
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
AMEX | DELAYED PRICE
| SECTOR | INDUSTRY |
| Consumer Staples | Beverages |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Endovia Health Sciences, Inc. engages in the manufacturing, distribution, marketing, and sale of various beverages in the United States. It operates in two segments Manufacture and Distribution of Non-Alcoholic and Alcoholic Beverages, and Retail Sale of Beverages and Groceries Online. The company offers flavored tequilas under the Chispo Tequila brand name; wine under the Copa DI Vino brand name; and sangria under the Pulpoloco Sangria brand name. It distributes its products through the business-to-business and business-to-consumer e-commerce distribution platform. The company was formerly known as Splash Beverage Group, Inc. and changed its name to Endovia Health Sciences, Inc. in August 2026. The company is based in Fort Lauderdale, Florida.
Financial Summary
| Share Statistics | EDVA | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1.7 | $7,892.1 | 1% |
|
| Shares Out (Mil) | 3.1 | 187.7 | 10% |
|
| Institutional Ownership | 86.4% | 50.0% | 54% |
|
| Float (Mil) | 6.3 | 175.1 | 14% |
|
| Beta | -1.09 | 0.46 | 1% |
|
| Avg Daily Volume (000s) | 463 | 213 | 59% |
|
| Price Change (52-week) |
(96.4%) | 82.0% | 2% |
|
| Growth | EDVA | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 6.1% | na |
|
| Net Income (5yr) | 2.6% | 4.8% | 43% |
|
| EPS (5yr) | 28.0% | 7.5% | 79 |
|
| Dividends (5yr) | 0.0% | 4.5% | 0% |
|
| Cash Flow (5yr) | (30.0%) | (18.3%) | 19% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | EDVA | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $5,531 | na |
|
| Net Income (TTM) (Mil) | ($17) | $311 | 25% |
|
| EPS (TTM) | ($13.601) | $0.400 | 4% |
|
| Operating Cash Flow (TTM) (Mil) | ($5) | $823 | 24% |
|
| Net Cash Flow (TTM) (Mil) | na | $34 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $1,013 | 0% |
|
| Enterprise Value (Q1) (Mil) | $8 | $10,443 | 7% |
|
| Valuation | EDVA | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.75 | na |
|
| P/E | na | 28.4 | na |
|
| Dividend Yield | na | 1.5% | na |
|
| PEG (5yr hist) | na | 2.8 | na |
|
| Ratios | EDVA | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 44.9% | na |
|
| Net Margin | na | 7.3% | na |
|
| ROA | (148.3%) | 4.0% | 3% |
|
| ROE | 491.6% | 11.2% | 99% |
|
| Liabilities to Assets | na | 55.0% | na |
|
| F-Score | 2 | 6 | na |
|
Endovia Health Sciences, Inc. did not pass any screens on 9/4/2026.
